Burden of Modifiable Risk Factors in Young-Onset Cryptogenic Ischemic Stroke by High-Risk Patent Foramen Ovale
Putaala, Jukka; Martinez-Majander, Nicolas; Leppert, Michelle; Tulkki, Lauri; Pirinen, Jani; Tolppanen, Heli; Sarkanen, Tomi; Virtanen, Marko; Jaakonmäki, Nina; Jäkälä, Pekka; Hedman, Marja; Redfors, Petra; Bech-Hanssen, Odd; Junttola, Ulla; Huhtakangas, Juha; Ylikotila, Pauli; Lautamäki, Riikka; Schminke, Ulf; von Sarnowski, Bettina; Busch, Raila; Yesilot, Nilüfer; Sezgin, Mine; Waje-Andreassen, Ulrike; Saeed, Sahrai; Fonseca, Ana Catarina; Paula, André; Amaya Pascasio, Laura; Martínez-Sánchez, Patricia; Kõrv, Janika; Muda, Piibe; Ferdinand, Phillip; Oxley, Cheryl; Zakarkaitė, Diana; Ryliškienė, Kristina; Pezzini, Alessandro; Lombardi, Carlo Mario; Líčeník, Radim; Zedde, Marialuisa; Grimaldi, Teresa; Tsivgoulis, Georgios; Sinisalo, Juha; Gerdts, Eva; Tatlisumak, Turgut; the SECRETO Study Group (2025-04-17)
Putaala, Jukka
Martinez-Majander, Nicolas
Leppert, Michelle
Tulkki, Lauri
Pirinen, Jani
Tolppanen, Heli
Sarkanen, Tomi
Virtanen, Marko
Jaakonmäki, Nina
Jäkälä, Pekka
Hedman, Marja
Redfors, Petra
Bech-Hanssen, Odd
Junttola, Ulla
Huhtakangas, Juha
Ylikotila, Pauli
Lautamäki, Riikka
Schminke, Ulf
von Sarnowski, Bettina
Busch, Raila
Yesilot, Nilüfer
Sezgin, Mine
Waje-Andreassen, Ulrike
Saeed, Sahrai
Fonseca, Ana Catarina
Paula, André
Amaya Pascasio, Laura
Martínez-Sánchez, Patricia
Kõrv, Janika
Muda, Piibe
Ferdinand, Phillip
Oxley, Cheryl
Zakarkaitė, Diana
Ryliškienė, Kristina
Pezzini, Alessandro
Lombardi, Carlo Mario
Líčeník, Radim
Zedde, Marialuisa
Grimaldi, Teresa
Tsivgoulis, Georgios
Sinisalo, Juha
Gerdts, Eva
Tatlisumak, Turgut
the SECRETO Study Group
American Heart Association
17.04.2025
Putaala, J., Martinez-Majander, N., Leppert, M., Tulkki, L., Pirinen, J., Tolppanen, H., Sarkanen, T., Virtanen, M., Jaakonmäki, N., Jäkälä, P., Hedman, M., Redfors, P., Bech-Hanssen, O., Junttola, U., Huhtakangas, J., Ylikotila, P., Lautamäki, R., Schminke, U., Von Sarnowski, B., … Subramonian, S. (2025). Burden of modifiable risk factors in young-onset cryptogenic ischemic stroke by high-risk patent foramen ovale. Stroke, STROKEAHA.124.049855. https://doi.org/10.1161/STROKEAHA.124.049855
https://creativecommons.org/licenses/by/4.0/
© 2025 The Authors. Stroke is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.
https://creativecommons.org/licenses/by/4.0/
© 2025 The Authors. Stroke is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.
https://creativecommons.org/licenses/by/4.0/
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi:oulu-202504232851
https://urn.fi/URN:NBN:fi:oulu-202504232851
Tiivistelmä
Abstract
BACKGROUND:
The incidence of young-onset ischemic stroke is rising, driven by cryptogenic ischemic stroke (CIS) and patients without vascular risk factors. This study examines the burden and associations of modifiable traditional, nontraditional, and female sex–specific risk factors with young-onset CIS, stratified by clinically relevant patent foramen ovale (PFO), defined by high-risk features of atrial septal aneurysm or large right-to-left shunt.
METHODS:
We enrolled consecutive patients aged 18 to 49 years with recent CIS and frequency-matched stroke-free controls of the same age and sex from 19 European sites. Logistic regression assessed the association of risk factor counts (12 traditional, 10 nontraditional, 5 female sex–specific) and individual risk factors, stratified by PFO. Analyses were stratified by sex and age (18–39 and 40–49 years), with computation of population-attributable risk.
RESULTS:
We included 523 patients (median age, 41 years; 47.3% women; 196 [37.5%] with PFO) and 523 controls. In patients with CIS without PFO, each additional traditional (odds ratio, 1.417 [95% CI, 1.282–1.568]), nontraditional (odds ratio, 1.702 [95% CI, 1.338–2.164]), and female sex–specific risk factor (odds ratio, 1.700 [95% CI, 1.107.1–2.611]) increased CIS risk. For patients with CIS with PFO, each traditional risk factor increased the risk (odds ratio, 1.185 [1.057–1.328]), but only nontraditional risk factors remained significant when fully adjusted (odds ratio, 2.656 [2.036–3.464]). Population-attributable risks for CIS without PFO were 64.7%, 26.5%, and 18.9% for traditional, nontraditional, and female sex–specific risk factors. For CIS with PFO, population-attributable risks were 33.8%, 49.4%, and 21.8%, respectively. Migraine with aura was the most significant contributor, with population-attributable risks of 45.8% for CIS with PFO and 22.7% for CIS without PFO, showing a stronger impact in women.
CONCLUSIONS:
Despite the initial cryptogenic label of these strokes, traditional risk factors significantly contribute to CIS without PFO, while nontraditional factors seem more critical for CIS with PFO. Migraine with aura plays a prominent role in young-onset CIS development, particularly in women.
REGISTRATION:
URL: https://www.clinicaltrials.gov; Unique identifier: NCT01934725.
BACKGROUND:
The incidence of young-onset ischemic stroke is rising, driven by cryptogenic ischemic stroke (CIS) and patients without vascular risk factors. This study examines the burden and associations of modifiable traditional, nontraditional, and female sex–specific risk factors with young-onset CIS, stratified by clinically relevant patent foramen ovale (PFO), defined by high-risk features of atrial septal aneurysm or large right-to-left shunt.
METHODS:
We enrolled consecutive patients aged 18 to 49 years with recent CIS and frequency-matched stroke-free controls of the same age and sex from 19 European sites. Logistic regression assessed the association of risk factor counts (12 traditional, 10 nontraditional, 5 female sex–specific) and individual risk factors, stratified by PFO. Analyses were stratified by sex and age (18–39 and 40–49 years), with computation of population-attributable risk.
RESULTS:
We included 523 patients (median age, 41 years; 47.3% women; 196 [37.5%] with PFO) and 523 controls. In patients with CIS without PFO, each additional traditional (odds ratio, 1.417 [95% CI, 1.282–1.568]), nontraditional (odds ratio, 1.702 [95% CI, 1.338–2.164]), and female sex–specific risk factor (odds ratio, 1.700 [95% CI, 1.107.1–2.611]) increased CIS risk. For patients with CIS with PFO, each traditional risk factor increased the risk (odds ratio, 1.185 [1.057–1.328]), but only nontraditional risk factors remained significant when fully adjusted (odds ratio, 2.656 [2.036–3.464]). Population-attributable risks for CIS without PFO were 64.7%, 26.5%, and 18.9% for traditional, nontraditional, and female sex–specific risk factors. For CIS with PFO, population-attributable risks were 33.8%, 49.4%, and 21.8%, respectively. Migraine with aura was the most significant contributor, with population-attributable risks of 45.8% for CIS with PFO and 22.7% for CIS without PFO, showing a stronger impact in women.
CONCLUSIONS:
Despite the initial cryptogenic label of these strokes, traditional risk factors significantly contribute to CIS without PFO, while nontraditional factors seem more critical for CIS with PFO. Migraine with aura plays a prominent role in young-onset CIS development, particularly in women.
REGISTRATION:
URL: https://www.clinicaltrials.gov; Unique identifier: NCT01934725.
Kokoelmat
- Avoin saatavuus [37690]